70.64  0.55 (0.78%)		02-19 15:59
Open: 69.9 High: 70.83 Volume: 13,689		Pre. Close: 70.09 Low: 69.9 Market Cap: 626(M)

Short term
Mid term
Targets	6-month :	83.03	1-year :	96.98
Resists	First :	71.08	Second :	83.03
Pivot price	70.09
Supports	First :	67.96	Second :	66.04
MAs	MA(5) :	70.36	MA(20) :	69.75
	MA(100) :	68.7	MA(250) :	68.04
MACD	MACD :	0.7	Signal :	0.7
%K %D	K(14,3) :	61.1	D(3) :	67.1
RSI	RSI(14): 60.8
52-week	High :	72.94	Low :	62.68

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ IHE ] has closed below upper band by 22.7%. Bollinger Bands are 47.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	70.24 - 70.52	70.52 - 70.76
Low:	68.94 - 69.29	69.29 - 69.59
Close:	69.49 - 70.06	70.06 - 70.54

The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund is non-diversified.

Wed, 12 Feb 2025
Best health care ETFs: Top biotech, pharma and medical funds - Bankrate.com

Tue, 21 Jan 2025
ETFs Poised to Win or Lose Under Trump's New Policies - TradingView

Mon, 11 Nov 2024
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - Nasdaq

Wed, 06 Nov 2024
Trump Has Asked Me To Do 3 Things, Says Robert Kennedy Jr. - Benzinga

Thu, 17 Oct 2024
ETFs in Focus Post JNJ Q3 Earnings Beat, Target Price Hike - Yahoo Finance

Wed, 17 Apr 2024
The 5 Best Pharmaceutical ETFs of 2023 - etf.com

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: AMEX
Sector: Financial Services
Industry: Asset Management
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.